权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular mechanisms of electrical remodeling in cardiac hypertrophy

心脏肥大电重塑的分子机制

基本信息

批准号：
8231417
负责人：
Saumya Das
金额：
$ 13.64万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-06-01 至 2013-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8231417
关键词：
1-Phosphatidylinositol 3-Kinase Action Potentials Address Adult Advisory Committees Animals Area Biochemical Biological Cardiac Cardiac Myocytes Cardiology Cardiovascular system Cells Clinical Congestive Heart Failure Data Development Dominant-Negative Mutation Echocardiography Educational Curriculum Electrophysiology (science)Event Fellowship Future General Hospitals Glucocorticoids Goals Grant Heart Heart Hypertrophy Heart failure Hypertrophy In Vitro Ion Channel Israel Joints Lead Link Massachusetts Mediator of activation protein Medical Medical center Medicine Mentorship Modeling Molecular Mus Myocardial Nature Neonatal Patients Phosphorylation Phosphotransferases Plasmids Potassium Principal Investigator Property Proteins Rattus Regulation Research Research Personnel Resources Role Serum Signal Pathway Signal Transduction Sodium Sodium Channel Source Stimulus Structure Techniques Testing Tetrodotoxin Tissues Training Transgenic Animals Transgenic Mice Transgenic Organisms Ventricular Arrhythmia Virus base career electrical property genetic manipulation hemodynamics in vivo insight mortality novel therapeutics patch clamp pressure professor programs research study response skills stressor sudden cardiac death trafficking voltage

项目摘要

DESCRIPTION (provided by applicant): This grant will support a 5-year period of rigorous training for the development of a career as an independent investigator in academic cardiac electrophysiology. The principal investigator has completed his clinical fellowship in cardiology and electrophysiology at Massachusetts General Hospital and seeks to expand his scientific skills using a unique integration of resources. This proposal seeks to investigate the mechanisms of electrical remodeling that accompany cardiac hypertrophy. The candidate will be under the joint mentorship of Dr. Anthony Rosenzweig, the Director of Cardiovascular Research at Beth Israel Deaconess Medical Center, who has expertise in the field of cardiac hypertrophy and kinase signaling pathways, and Dr. Patrick Ellinor, Assistant Professor of Medicine at MGH, who has expertise in the field of cardiac ion channel structure-function. A curriculum encompassing both research and didactic training will be devised to further the training of the candidate, and an advisory committee of leading medical researchers will provide scientific and career advice. Sudden cardiac death and ventricular arrhythmias (VA) are a leading source of mortality in patients with congestive heart failure. Myocardial hypertrophy precedes heart failure and is an independent predictor of VAs. However, the signaling cascades that link hypertrophy to the electrical remodeling that comprises the substrate and is the source of triggers of lethal VAs are not well understood as yet. We have recently shown that the PI-3 kinase-dependent serum glucocorticoid-responsive kinase (SGK-1) can modulate cardiac hypertrophy in response to diverse stimuli. SGK-1 uniquely targets several ion channels, and our new and exciting preliminary data suggest that SGK-1 can phosphorylate and alter the trafficking of the voltage-gated cardiac sodium channel SCNSa in cardiomyocytes. The overall goal of the proposal is to test the hypothesis that SGK-1 is an important mediator of the electrical remodeling in cardiac hypertrophy by addressing the following specific aims. We propose 1) To determine if SGK-1 is necessary and sufficient for hypertrophy-induced changes in SCNSa. 2) To examine the role of SGK-1 in regulation of SCNSa function, and 3) To evaluate if SGK-1 is a mediator of electrical remodeling associated with cardiac hypertrophy. These aims will be achieved using a combination of biochemical, molecular biological and electrophysiological techniques in vitro as well as by in vivo studies in mice subject to genetic manipulation. Completion of these aims will provide a deeper understanding of the molecular basis of cardiac electrical remodeling. Insights into the critical mechanistic links between hypertrophy and electrical remodeling may lead to newer therapeutic options in an area of great clinical importance. Furthermore the proposal will serve as an ideal platform for the candidate to make the transition to an independent investigator.

描述（由申请人提供）：这笔赠款将支持为期5年的严格培训，以发展职业生涯，学术心脏电生理学的独立研究者。首席研究员已完成他在马萨诸塞州总医院心脏病学和电生理学的临床研究金，并寻求利用独特的资源整合来扩展他的科学技能。这项建议旨在调查伴随心脏肥大的电重构机制。候选人将在 Beth Israel心血管研究主任Anthony Rosenzweig博士的联合指导 Deaconess Medical Center，她在心脏肥大和激酶信号传导领域拥有专业知识途径，和博士帕特里克Ellinor，医学助理教授在MGH，谁在该领域的专业知识，心脏离子通道结构-功能。包括研究和教学培训的课程将旨在进一步培训候选人，以及由领先的医学研究人员组成的咨询委员会将提供科学和职业建议。心脏性猝死和室性心律失常（VA）是心脏病患者死亡的主要原因。充血性心力衰竭心肌肥厚先于心力衰竭，是心力衰竭的独立预测因子。退伍军人协会然而，将肥大与电重构联系起来的信号级联，底物，是致命VA的触发源还没有很好地理解。我们最近的研究表明 PI-3激酶依赖性血清糖皮质激素反应性激酶（SGK-1）可调节心脏对不同刺激的反应。SGK-1独特地靶向几个离子通道，我们的新的和令人兴奋的初步数据表明，SGK-1可以磷酸化和改变电压门控的运输，心肌细胞中的心脏钠通道SCNSa。该提案的总体目标是检验假设 SGK-1是心肌肥厚时电重构的重要介质，具体目标。我们建议1）确定SGK-1是否是必要的和充分的，肥大引起的SCNSa变化。2)研究SGK-1在SCNS α调节中的作用 3）评估SGK-1是否是与心脏功能相关的电重构的介导剂，肥厚这些目标将通过生物化学、分子生物学和生物技术的结合来实现。通过体外电生理技术以及在经受遗传操作的小鼠中的体内研究，这些目标的完成将使我们更深入地了解心脏电生理的分子基础。重塑深入了解肥大和电重构之间的关键机制联系，从而在具有重要临床意义领域中产生更新的治疗选择。此外，该提案将有助于作为候选人过渡到独立调查员的理想平台。

项目成果

期刊论文数量（4）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Ion-selective optodes measure extracellular potassium flux in excitable cells.

DOI：
10.1002/marc.200900297
发表时间：
2010-01-18
期刊：
MACROMOLECULAR RAPID COMMUNICATIONS
影响因子：
4.6
作者：
Harjes, Daniel I.;Dubach, J. Matthew;Rosenzweig, Anthony;Das, Saumya;Clark, Heather A.
通讯作者：
Clark, Heather A.

Pseudo-atrial fibrillation due to non-reentrant AV nodal tachycardia.

非折返性房室结心动过速引起的假性心房颤动。